Evidence map›Paper›PMID 40986356›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Targeting endothelial ERG to mitigate vascular regression in retinopathies.

Eric Ma, Christopher M Schafer, Jun Xie, Yelyzaveta Rudenko, John T H Knapp, Anna M Randi, Graeme M Birdsey, Courtney T Griffin

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Eric Ma *Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.
Christopher M Schafer *Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.ORCID 0000-0002-5859-7714
Jun XieCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.
Yelyzaveta RudenkoCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.ORCID 0009-0002-0464-0139
John T H KnappCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.ORCID 0009-0004-6755-9498
Anna M RandiNational Heart and Lung Institute, Imperial College London, London W12 0NN, United Kingdom.
Graeme M BirdseyNational Heart and Lung Institute, Imperial College London, London W12 0NN, United Kingdom.ORCID 0000-0002-0981-8672
Courtney T GriffinCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.ORCID 0000-0001-8100-3171

Funding

Viral sensor IFIH1 promotes SLE through an altered interferon programP20GM139763 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI Kenneth M Humphries · 2021 to 2026
$20.3M
Protease-Mediated Vascular Instability in Development and DiseaseR35HL144605 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GRIFFIN, COURTNEY T · 2019 to 2025
$5.9M
American Heart Association (AHA) 23SCEFIA1155941American Heart Association (AHA) 24POST1196957ARVO Foundation for Eye Research (AFER) EyeFind Research GrantBritish Heart Foundation (BHF) RG/11/17/29256British Heart Foundation (BHF) RG/17/4/32662HHS | NIH (NIH) P20GM139763HHS | NIH (NIH) R35HL144605NHLBI NIH HHS R35 HL144605NIGMS NIH HHS P20 GM139763
6 · The paper itself

Abstract

Retinopathy of prematurity (ROP) and diabetic retinopathy (DR) are ocular disorders in which an initial loss of retinal capillaries leads to damaging tissue ischemia followed by a compensatory neovascularization response that generates pathological capillaries in the eye. Using a mouse model of ROP and samples from DR patients, we found that the highly homologous and homeostatic erythroblast transformation-specific (ETS) family transcription factors ETS-related gene (ERG) and Friend leukemia integration 1 (FLI1) are downregulated in endothelial cells (ECs) of retinal capillaries prior to their regression in early stages of these diseases. We developed a mouse model of inducible EC-specific overexpression of

Indexed as

Diabetes Mellitus, ExperimentalDiabetic RetinopathyRetinal NeovascularizationRetinopathy of PrematurityTranscriptional Regulator ERGAnimalsCapillariesDown-RegulationEndothelial CellsFemaleHumansMaleMiceMice, Inbred C57BLMice, TransgenicOncogene ProteinsERG protein, humanERG protein, mouseFLI1 protein, humanFli1 protein, mouseOncogene ProteinsProto-Oncogene Protein c-fli-1StreptozocinTranscriptional Regulator ERGdiabetic retinopathymicrovascular rarefactionretinaretinopathy of prematuritytranscriptional regulator ERG

Identifiers

PMID40986356
PMCPMC12501155

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.